RELATED CONTENT
NEWS
- Pradaxa finally wins English warfarin replacement race, despite appeal
- Patient access scheme prompts NICE U-turn on Novartis' Tasigna, while BMS will appeal against no for Sprycel
- NICE no for Tyverb and Herceptin in breast cancer, Roche considers appeal
- Roche pins Tarceva hope on Cancer Drugs Fund after NICE rejects appeal
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK

Section Head (m/f)
DRA International/CIS Section

Section Head (m/f)
DRA International/CIS Section

